D.Med Medical Services GmbH gladly announces the purchase of the Turkish operations of Swedish Diaverum Group. Today, 19 clinics in 11 different cities are operated where more than 2,200 patients are treated, served by 500 employees including 33 Doctors, 4 Nephrologists, 171 Dialysis Nurses. Diaverum Diyaliz Hizmetleri A.Ş. is the second biggest renal care provider…
D.Med Healthcare GmbH & Co. KG and Hebei Changshan Pharmaceutical (Hongkong) Co. Ltd., 100% subsidiary of the stock-listed Chinese manufacturer of pharmaceutical products, Hebei Changshan Biomedical Pharmaceutical Co. Ltd. (Shenzhen Stock Exchange / SIN 300255:CH), announce the set-up of a joint venture aiming at the production and marketing of Heparin formulations. TAGS Press ReleaseAdquisitionsGrowthHaemodialysis MarketGlobalDialysis…
With a goal to provide affordable dialysis services and training in India while adhering to German and international standards, D.Med Medical Services GmbH entered into a partnership with India-based (Pune) Biomed. This move is a natural next step in D.med’s growth to become a global name in Renal care. Through GRC, D.med will bring its…
In order to strengthen its role in the production, sales, marketing and further development of the highly innovative Gynedil dilation devices (www.gynedil.com), D.Med Healthcare AG has increased its share in Belgrade-based Inove d.o.o., the manufacturer of Gynedil, from 10 to 54.5% by taking over the shares of the company’s founder Dobrivoje Rajkovic. This deal underlines…